Aktis Oncology, Inc.AKTSNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank0
Studio
Year-over-Year Change

Enterprise value to sales ratio

Latest
-16.91
↓ 200% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineCompressed
Average
-5.64
Historical baseline
PeriodValueYoY Change
2024-16.91-
20230.00-
20220.00-